2024年3月16日发(作者：种子搜索神器 bt 下载)

how to cope with anxiety 作文

How much help can be expected from drugs?

Minor tranquillizers (such asthe benzodiazepines) seem on the

surface to be aneasy way of controlling discomfort. Problems withtheir use in long-term

anxiety have already situation that existed 10 years ago ischanging.

Many people who would have takendiazepam for tension, as readily as taking aspirin

fora headache, are now more concerned about the habit-forming more people

see a prescription fora minor tranquillizer as a medical brush off: 'All hegave me was

more of those little yellow tablets'-agood pharmaceutical example of familiarity

breedingcontempt. When asked for advice about their valuethe patient should be told

that tranquillizers shouldbe restricted to those situations where reactiontoacutestress

proves intolerable. Furthermore,bettercontrol of anxiety is likely if the patient is asked

tomonitor his own symptoms, only taking a tablet whena certain anxiety level is reached,

while not exceedinga certain maximum dose each day.

There may also be a role for minor tranquillizers inthe treatment of insomnia. In this

situation there aregood arguments

forrelyingonshortactingvarietiessuchasoxazepam,temazepam,lorazepam and tria-zolam.

Anti-depressants. Tricyclics，such as imipramine,have been shown to be effective in

reducing anxiety,particularly when manifested in the form of intermit-tent panic

group of drugs is not habitforming,so if a drug approach is

favoured,theywould appear to have a clear advantage over thebenzodiazepines.

Unfortunately，about 20% of pa-tients on tricyclics discontinue treatment

presumablybecause of side effects, and at least 2 out of 3 patientsrelapse when

treatment is stopped. Symptoms re-spond even better to monoamine oxidase

inhibitors,buthere the essential dietary restrictions proveirksome，the relapse rate

following withdrawal ofmedication is extremely high，and there is growingevidence that

dependency can develop.

Major tranquillizers. Major tranquillizers such astrifluoparazine are sometimes

prescribed in low dosesto relieve symptoms of anxiety when there is noquestion of any

psychotic disorder. While there islittle or no risk of dependence with this group

ofdrugs,the possibility of producing serious parkins-onian side effects should

contraindicate their use inthe management of chronic anxiety.

Beta blockers. Beta blockers appeared to haveconsiderable potential in the

treatment of anxietywhen first introduced. From their pharmacologicalproperties，it

could be predicted that they shouldreduce the peripheral effects of anxiety, but have

fewif any central prediction was verified r, subsequent

clinical trials failed toconfirm their value in the vast majority of cases ofanxiety，the only

exception being a demonstrablebenefit in reducing the disruptive effect of perfor-mance

anxiety，particularly in musicians and publicspeakers.